Janssen Pharmaceuticals (English Wikipedia)

Marcial G (4 May 2009). "Marcial: Medarex, a Bright Spot in Biotech". Bloomberg Businessweek. Archived from the original on 25 September 2014. Retrieved 24 September 2014.

biospace.com

"XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen". BioSpace. Retrieved 4 May 2020.
"Janssen to Acquire Investigational Bermekimab from XBiotech". BioSpace. Retrieved 4 May 2020.

bizjournals.com

George J (26 October 1998). "Centocor making its mark in biotech". Philadelphia Business Journal. Retrieved 4 May 2020.
George J (26 October 2011). "Johnson & Johnson '05 plant explosion: A lesson learned". Philadelphia Business Journal.
Bishop T (24 May 1999). "Centocor profit growth best among Phila. Inc". Philadelphia Business Journal.
George J. "Remicade maker Centocor Ortho Biotech changing name". Philadelphia Business Journal. Retrieved 15 January 2019.

bloomberg.com

"Janssen Vaccines AG". Bloomberg L.P. 2020.
J&J Said to Agree to $2.2 Billion Drug Marketing Accord Bloomberg News. By Margaret Cronin Fisk, Jef Feeley & David Voreacos – 11 June 2012

businessweek.com

Marcial G (4 May 2009). "Marcial: Medarex, a Bright Spot in Biotech". Bloomberg Businessweek. Archived from the original on 25 September 2014. Retrieved 24 September 2014.

bvapublications.com

veterinaryrecord.bvapublications.com

De Vos V (1978). "Immobilisation of Free-ranging Wild Animals Using a New Drug". Veterinary Record. 103 (4): 64–8. doi:10.1136/vr.103.4.64 (inactive 1 November 2024). PMID 685103. S2CID 36314586. Retrieved 27 September 2010.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)

cnn.com

Kuznia R, Polglase K, Mezzofiore G (1 May 2020). "In quest for vaccine, US makes 'big bet' on company with unproven technology". CNN. Retrieved 2 May 2020.

doi.org

Lopez-Munoz F, Alamo C (2009). "The Consolidation of Neuroleptic Therapy: Janssen, the Discovery of Haloperidol and Its Introduction into Clinical Practice". Brain Research Bulletin. 79 (2): 130–141. doi:10.1016/j.brainresbull.2009.01.005. PMID 19186209. S2CID 7720401.
Janssen PA, Eddy NB (1960). "Compounds related to pethidine-IV new general chemical methods of increasing the analgesic activity of pethidine" (PDF). Journal of Medicinal and Pharmaceutical Chemistry. 2 (1): 31–45. doi:10.1021/jm50008a003. PMID 14406754. Retrieved 27 September 2010.^{[permanent dead link]}
Morgan M, Lumley J, Whitwam JG (1975). "Etomidate, a new water-soluble non-barbiturate intravenous induction agent". The Lancet. 305 (7913): 955–6. doi:10.1016/S0140-6736(75)92011-5. PMID 48126. S2CID 205992130.
Spierdijk J, van Kleef J, Nauta J, Stanley TH, de Lange S (1980). "Alfentanil: a new narcotic induction agent". Anesthesiology. 53: S32. doi:10.1097/00000542-198009001-00032.
Niemegeers CJ, Janssen PA (1981). "Alfentanil (R39209)-a particularly short acting intravenous narcotic analgesic in rats". Drug Development Research. 1: 830–8. doi:10.1002/ddr.430010111. ISSN 0272-4391. S2CID 84794527.
De Vos V (1978). "Immobilisation of Free-ranging Wild Animals Using a New Drug". Veterinary Record. 103 (4): 64–8. doi:10.1136/vr.103.4.64 (inactive 1 November 2024). PMID 685103. S2CID 36314586. Retrieved 27 September 2010.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)

fdi.com

Centocor reaches agreement to sell oncology diagnostics business, 1998 press release

fiercepharma.com

"Johnson & Johnson, BARDA join forces to prep for pandemic flu, inking deal for vaccine and drug R&D – FiercePharma". fiercepharma.com. Retrieved 12 April 2018.

forbes.com

Brewster T (30 March 2020). "The U.S. Just Signed A$450 Million Coronavirus Vaccine Contract With Johnson & Johnson". Forbes. Retrieved 2 May 2020.
J&J needs a cure: new CEO allegedly had links to fraud Forbes, Erika Kelton, 17 April 2012

genengnews.com

"GEN – News Highlights:Kura Oncology Licenses Janssen's Tipofarnib in Cancer". GEN.
"GEN – News Highlights:Galapagos Regains Rights to GLPG1690 from Janssen". GEN. 17 March 2015.
"Janssen, MacroGenics Launch Up-to-$740M+ Second Collaboration". GEN. 18 May 2016.
"Janssen Joins MacroGenics in Up-to-$700M Cancer Collaboration". GEN – Genetic Engineering and Biotechnology News. 22 December 2014. Retrieved 11 December 2019.
"Janssen, Isis Pharma Ink Up-to-$835M Antisense Agreement". GEN – Genetic Engineering and Biotechnology News. 5 January 2015. Retrieved 11 December 2019.

infogrok.com

Centocor Ortho Biotech Acquires RespiVert Archived 5 June 2010 at the Wayback Machine News article from InfoGrok.

janssen.com

"Janssen Announces U.S. FDA Approval of SPRAVATO™ (esketamine) CIII Nasal Spray for Adults with Treatment-Resistant Depression (TRD) Who Have Cycled Through Multiple Treatments Without Relief". Janssen. Archived from the original on 25 November 2020. Retrieved 7 March 2019.

malariavaccine.org

"Janssen (formerly Crucell)". PATH Malaria Vaccine Initiative. 2020. Archived from the original on 4 April 2023. Retrieved 14 March 2021.

nih.gov

pubmed.ncbi.nlm.nih.gov

Lopez-Munoz F, Alamo C (2009). "The Consolidation of Neuroleptic Therapy: Janssen, the Discovery of Haloperidol and Its Introduction into Clinical Practice". Brain Research Bulletin. 79 (2): 130–141. doi:10.1016/j.brainresbull.2009.01.005. PMID 19186209. S2CID 7720401.
Janssen PA, Eddy NB (1960). "Compounds related to pethidine-IV new general chemical methods of increasing the analgesic activity of pethidine" (PDF). Journal of Medicinal and Pharmaceutical Chemistry. 2 (1): 31–45. doi:10.1021/jm50008a003. PMID 14406754. Retrieved 27 September 2010.^{[permanent dead link]}
Janssen PA, Niemegeers CJ, Dony JG (1963). "The inhibitory effect of fentanyl and other morphine like analgesics on the warm water induced tail withdrawal reflex in rats" (PDF). Arzneimittel-Forschung. 13: 502–7. ISSN 0004-4172. PMID 13957426. Retrieved 27 September 2010.
Janssen PA, Niemegeers CJ, Schellekens KH, Verbruggen FJ, Van Nueten JM (1963). "The pharmacology of dehydrobenzperidol, a new potent and short-acting neuroleptic agent chemically related to haloperidol". Arzneimittel-Forschung. 13: 205–11. ISSN 0004-4172. PMID 13957425.
Doenicke A, Kugler J, Penzel G, Laub M, Kalmar L, Kilian I, Bezecny H (1973). "[Cerebral Function under Etomidate, a New Non-Barbiturate I.V. Hypnotic]". Der Anaesthesist (in German). 22 (8): 353–66. ISSN 0003-2417. PMID 4584133. Archived from the original on 20 July 2011. Retrieved 27 September 2010.
Morgan M, Lumley J, Whitwam JG (1975). "Etomidate, a new water-soluble non-barbiturate intravenous induction agent". The Lancet. 305 (7913): 955–6. doi:10.1016/S0140-6736(75)92011-5. PMID 48126. S2CID 205992130.
Niemegeers CJ, Schellekens JH, van Bever WF, Janssen PA (1976). "Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs". Arzneimittel-Forschung. 26 (8): 1551–6. ISSN 0004-4172. PMID 12772.
De Vos V (1978). "Immobilisation of Free-ranging Wild Animals Using a New Drug". Veterinary Record. 103 (4): 64–8. doi:10.1136/vr.103.4.64 (inactive 1 November 2024). PMID 685103. S2CID 36314586. Retrieved 27 September 2010.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)

nootropicsfrontline.com

Janssen PA, Eddy NB (1960). "Compounds related to pethidine-IV new general chemical methods of increasing the analgesic activity of pethidine" (PDF). Journal of Medicinal and Pharmaceutical Chemistry. 2 (1): 31–45. doi:10.1021/jm50008a003. PMID 14406754. Retrieved 27 September 2010.^{[permanent dead link]}

nytimes.com

Nir SM (29 June 2021). "Major Trial Against Opioid Suppliers Begins in New York". The New York Times. ISSN 0362-4331. Retrieved 1 July 2021.
Nir SM (26 June 2021). "Johnson & Johnson to Pay New York $230 Million to Settle Opioid Case". The New York Times. ISSN 0362-4331. Retrieved 1 July 2021.
Saul S (21 February 2007). "Drug Gets a Cameo in a Film Backed by Its Maker". The New York Times. ISSN 0362-4331.
Singer, Natasha (15 January 2010). "Johnson & Johnson Accused of Drug Kickbacks". The New York Times. Retrieved 17 January 2010.
J.&J. Fined $1.2 Billion in Drug Case NY Times, By KATIE THOMAS Published: 11 April 2012

semanticscholar.org

api.semanticscholar.org

Lopez-Munoz F, Alamo C (2009). "The Consolidation of Neuroleptic Therapy: Janssen, the Discovery of Haloperidol and Its Introduction into Clinical Practice". Brain Research Bulletin. 79 (2): 130–141. doi:10.1016/j.brainresbull.2009.01.005. PMID 19186209. S2CID 7720401.
Morgan M, Lumley J, Whitwam JG (1975). "Etomidate, a new water-soluble non-barbiturate intravenous induction agent". The Lancet. 305 (7913): 955–6. doi:10.1016/S0140-6736(75)92011-5. PMID 48126. S2CID 205992130.
Niemegeers CJ, Janssen PA (1981). "Alfentanil (R39209)-a particularly short acting intravenous narcotic analgesic in rats". Drug Development Research. 1: 830–8. doi:10.1002/ddr.430010111. ISSN 0272-4391. S2CID 84794527.
De Vos V (1978). "Immobilisation of Free-ranging Wild Animals Using a New Drug". Veterinary Record. 103 (4): 64–8. doi:10.1136/vr.103.4.64 (inactive 1 November 2024). PMID 685103. S2CID 36314586. Retrieved 27 September 2010.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)

semanticscholar.org

Morgan M, Lumley J, Whitwam JG (1975). "Etomidate, a new water-soluble non-barbiturate intravenous induction agent". The Lancet. 305 (7913): 955–6. doi:10.1016/S0140-6736(75)92011-5. PMID 48126. S2CID 205992130.

tematicas.es

Doenicke A, Kugler J, Penzel G, Laub M, Kalmar L, Kilian I, Bezecny H (1973). "[Cerebral Function under Etomidate, a New Non-Barbiturate I.V. Hypnotic]". Der Anaesthesist (in German). 22 (8): 353–66. ISSN 0003-2417. PMID 4584133. Archived from the original on 20 July 2011. Retrieved 27 September 2010.

theintell.com

Crissa Shoemaker DeBree (22 June 2011). "Centocor is now Janssen Biotech". The Intelligencer. Gannett Co.

thepharmaletter.com

"Trend For 1997 Strong Sales Continues In USA – Pharmaceutical industry". thepharmaletter.com. Retrieved 4 May 2020.

upenn.edu

garfield.library.upenn.edu

Janssen PA, Niemegeers CJ, Dony JG (1963). "The inhibitory effect of fentanyl and other morphine like analgesics on the warm water induced tail withdrawal reflex in rats" (PDF). Arzneimittel-Forschung. 13: 502–7. ISSN 0004-4172. PMID 13957426. Retrieved 27 September 2010.

washingtonpost.com

Hilzenrath, David S. (16 January 2010). "Justice suit accuses Johnson & Johnson of paying kickbacks". The Washington Post. Retrieved 17 January 2010.

web.archive.org

"Janssen (formerly Crucell)". PATH Malaria Vaccine Initiative. 2020. Archived from the original on 4 April 2023. Retrieved 14 March 2021.
"Janssen Announces U.S. FDA Approval of SPRAVATO™ (esketamine) CIII Nasal Spray for Adults with Treatment-Resistant Depression (TRD) Who Have Cycled Through Multiple Treatments Without Relief". Janssen. Archived from the original on 25 November 2020. Retrieved 7 March 2019.
Centocor Ortho Biotech Acquires RespiVert Archived 5 June 2010 at the Wayback Machine News article from InfoGrok.
Doenicke A, Kugler J, Penzel G, Laub M, Kalmar L, Kilian I, Bezecny H (1973). "[Cerebral Function under Etomidate, a New Non-Barbiturate I.V. Hypnotic]". Der Anaesthesist (in German). 22 (8): 353–66. ISSN 0003-2417. PMID 4584133. Archived from the original on 20 July 2011. Retrieved 27 September 2010.

worldcat.org

search.worldcat.org

Nir SM (29 June 2021). "Major Trial Against Opioid Suppliers Begins in New York". The New York Times. ISSN 0362-4331. Retrieved 1 July 2021.
Nir SM (26 June 2021). "Johnson & Johnson to Pay New York $230 Million to Settle Opioid Case". The New York Times. ISSN 0362-4331. Retrieved 1 July 2021.
Langreth R (22 July 1999). "Johnson & Johnson to Purchase Centocor for $4.9 Billion in Stock". The Wall Street Journal. ISSN 0099-9660. Retrieved 4 May 2020.
Saul S (21 February 2007). "Drug Gets a Cameo in a Film Backed by Its Maker". The New York Times. ISSN 0362-4331.
Janssen PA, Niemegeers CJ, Dony JG (1963). "The inhibitory effect of fentanyl and other morphine like analgesics on the warm water induced tail withdrawal reflex in rats" (PDF). Arzneimittel-Forschung. 13: 502–7. ISSN 0004-4172. PMID 13957426. Retrieved 27 September 2010.
Janssen PA, Niemegeers CJ, Schellekens KH, Verbruggen FJ, Van Nueten JM (1963). "The pharmacology of dehydrobenzperidol, a new potent and short-acting neuroleptic agent chemically related to haloperidol". Arzneimittel-Forschung. 13: 205–11. ISSN 0004-4172. PMID 13957425.
Doenicke A, Kugler J, Penzel G, Laub M, Kalmar L, Kilian I, Bezecny H (1973). "[Cerebral Function under Etomidate, a New Non-Barbiturate I.V. Hypnotic]". Der Anaesthesist (in German). 22 (8): 353–66. ISSN 0003-2417. PMID 4584133. Archived from the original on 20 July 2011. Retrieved 27 September 2010.
Niemegeers CJ, Schellekens JH, van Bever WF, Janssen PA (1976). "Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs". Arzneimittel-Forschung. 26 (8): 1551–6. ISSN 0004-4172. PMID 12772.
Niemegeers CJ, Janssen PA (1981). "Alfentanil (R39209)-a particularly short acting intravenous narcotic analgesic in rats". Drug Development Research. 1: 830–8. doi:10.1002/ddr.430010111. ISSN 0272-4391. S2CID 84794527.

wsj.com

Langreth R (22 July 1999). "Johnson & Johnson to Purchase Centocor for $4.9 Billion in Stock". The Wall Street Journal. ISSN 0099-9660. Retrieved 4 May 2020.